Beryl Drugs Limited (BERLDRG.BO)
INR 22.98
(-0.09%)
INR 22.98
(-0.09%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 93.77 Million INR | 35.23% |
| 2022 | 69.34 Million INR | 48.37% |
| 2021 | 46.73 Million INR | 11.47% |
| 2020 | 41.92 Million INR | 13.07% |
| 2019 | 37.08 Million INR | 19.39% |
| 2018 | 31.05 Million INR | 4.92% |
| 2017 | 29.59 Million INR | -4.92% |
| 2016 | 31.13 Million INR | -22.64% |
| 2015 | 40.23 Million INR | 46.14% |
| 2014 | 27.53 Million INR | 7.37% |
| 2013 | 25.64 Million INR | 20.84% |
| 2012 | 21.22 Million INR | 61.52% |
| 2011 | 13.13 Million INR | 0.69% |
| 2010 | 13.04 Million INR | -2.49% |
| 2009 | 13.38 Million INR | -0.27% |
| 2008 | 13.41 Million INR | -77.71% |
| 2007 | 60.19 Million INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 13.53 Million INR | 506.89% |
| 2023 Q2 | 42.76 Million INR | 16.63% |
| 2023 Q3 | 31.11 Million INR | -27.24% |
| 2023 Q1 | 36.66 Million INR | 390.52% |
| 2023 FY | 93.77 Million INR | 35.23% |
| 2023 Q4 | -3.32 Million INR | -110.69% |
| 2022 Q4 | -12.62 Million INR | -135.89% |
| 2022 FY | 69.34 Million INR | 48.37% |
| 2022 Q1 | 20.05 Million INR | 583.46% |
| 2022 Q2 | 26.74 Million INR | 33.36% |
| 2022 Q3 | 35.16 Million INR | 31.48% |
| 2021 Q3 | 14.88 Million INR | -17.59% |
| 2021 Q4 | -4.14 Million INR | -127.86% |
| 2021 FY | 46.73 Million INR | 11.47% |
| 2021 Q1 | 17.81 Million INR | 349.9% |
| 2021 Q2 | 18.06 Million INR | 1.39% |
| 2020 Q1 | 13.36 Million INR | 303.9% |
| 2020 FY | 41.92 Million INR | 13.07% |
| 2020 Q3 | 15.16 Million INR | 60.78% |
| 2020 Q4 | 3.96 Million INR | -73.89% |
| 2020 Q2 | 9.43 Million INR | -29.4% |
| 2019 Q2 | 14.96 Million INR | -7.51% |
| 2019 FY | 37.08 Million INR | 19.39% |
| 2019 Q1 | 16.18 Million INR | 256.54% |
| 2019 Q3 | 10.67 Million INR | -28.71% |
| 2019 Q4 | -6.55 Million INR | -161.42% |
| 2018 Q4 | -10.33 Million INR | -174.81% |
| 2018 Q3 | 13.82 Million INR | -6.22% |
| 2018 FY | 31.05 Million INR | 4.92% |
| 2018 Q1 | 12.83 Million INR | 234.32% |
| 2018 Q2 | 14.73 Million INR | 14.79% |
| 2017 Q1 | 9.89 Million INR | -59.5% |
| 2017 Q4 | 3.84 Million INR | -58.24% |
| 2017 Q3 | 9.19 Million INR | 36.58% |
| 2017 FY | 29.59 Million INR | -4.92% |
| 2017 Q2 | 6.73 Million INR | -31.94% |
| 2016 Q1 | 4.64 Million INR | -37.91% |
| 2016 FY | 31.13 Million INR | -22.64% |
| 2016 Q4 | 24.42 Million INR | 254.24% |
| 2016 Q3 | 6.89 Million INR | 24.41% |
| 2016 Q2 | 5.54 Million INR | 19.31% |
| 2015 Q3 | 9.5 Million INR | -25.67% |
| 2015 Q4 | 7.48 Million INR | -21.29% |
| 2015 Q2 | 12.78 Million INR | 141.98% |
| 2015 FY | 40.23 Million INR | 46.14% |
| 2015 Q1 | 5.28 Million INR | 1375.1% |
| 2014 Q4 | -414.39 Thousand INR | -104.12% |
| 2014 FY | 27.53 Million INR | 7.37% |
| 2014 Q1 | 10.56 Million INR | 3965.0% |
| 2014 Q2 | 8.11 Million INR | -23.25% |
| 2014 Q3 | 10.05 Million INR | 23.99% |
| 2013 Q2 | 7.97 Million INR | -18.46% |
| 2013 FY | 25.64 Million INR | 20.84% |
| 2013 Q1 | 9.78 Million INR | 312.04% |
| 2013 Q3 | 7.65 Million INR | -4.01% |
| 2013 Q4 | 260 Thousand INR | -96.6% |
| 2012 Q1 | 8.87 Million INR | 45.36% |
| 2012 Q4 | -4.61 Million INR | -136.67% |
| 2012 FY | 21.22 Million INR | 61.52% |
| 2012 Q3 | 12.58 Million INR | 187.08% |
| 2012 Q2 | 4.38 Million INR | -50.61% |
| 2011 FY | 13.13 Million INR | 0.69% |
| 2011 Q4 | 6.1 Million INR | 182.59% |
| 2011 Q3 | 2.16 Million INR | 0.0% |
| 2010 FY | 13.04 Million INR | -2.49% |
| 2009 FY | 13.38 Million INR | -0.27% |
| 2008 Q4 | 17.6 Million INR | 0.0% |
| 2008 FY | 13.41 Million INR | -77.71% |
| 2007 FY | 60.19 Million INR | 0.0% |
| 2007 Q4 | 16.46 Million INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| ANG Lifesciences India Limited | 219.92 Million INR | 57.363% |
| DECIPHER LABS LIMITED | 277.6 Million INR | 66.221% |
| Ishita Drugs and Industries Limited | 16.46 Million INR | -469.448% |
| Jenburkt Pharmaceuticals Limited | 437.2 Million INR | 78.552% |
| Patidar Buildcon Limited | 1.81 Million INR | -5077.858% |
| Sanjivani Paranteral Limited. | 208.87 Million INR | 55.107% |
| SHAMROCK INDUSTRIAL CO.LTD. | 1.52 Million INR | -6052.953% |
| Source Natural Foods and Herbal Supplements Limited | 31.85 Million INR | -194.35% |
| Sunil Healthcare Limited | 438.1 Million INR | 78.596% |
| MedPlus Health Services Limited | 2.42 Billion INR | 96.132% |
| KIMIA BIOSCIENCES LIMITED | 149.52 Million INR | 37.286% |
| Add-Shop E-Retail Limited | 146.52 Million INR | 36.004% |
| Bacil Pharma Limited | 1.87 Million INR | -4902.748% |
| BDH Industries Limited | 57.03 Million INR | -64.418% |
| Cian Healthcare Limited | 59.19 Million INR | -58.4% |
| Concord Drugs Limited | 91.83 Million INR | -2.111% |
| Deccan Health Care Limited | 36.24 Million INR | -158.736% |
| Gujarat Terce Laboratories Limited | 132.41 Million INR | 29.186% |
| Gujarat Themis Biosyn Limited | 156.84 Million INR | 40.215% |
| Medi-Caps Limited | 93.11 Million INR | -0.701% |
| Parmax Pharma Limited | 99.31 Million INR | 5.584% |
| Sastasundar Ventures Limited | 846.78 Million INR | 88.926% |
| Smruthi Organics Limited | 261.73 Million INR | 64.173% |
| SUDARSHAN PHARMA INDUSTRIES LI | 146.09 Million INR | 35.813% |
| Phaarmasia Limited | 50.52 Million INR | -85.59% |
| Syschem (India) Limited | 64.13 Million INR | -46.216% |
| Transchem Limited | 8.47 Million INR | -1006.704% |
| Trinity League India Limited | -1.08 Million INR | 8734.53% |
| Tyche Industries Limited | 182.04 Million INR | 48.489% |
| Vista Pharmaceuticals Limited | 20.16 Million INR | -364.996% |
| Zenith Healthcare Limited | 45.97 Million INR | -103.948% |
| Chemo Pharma Laboratories Limited | 1.94 Million INR | -4716.179% |
| Colinz Laboratories Limited | 31.19 Million INR | -200.567% |
| Denis Chem Lab Limited | 453.36 Million INR | 79.317% |
| Hindustan Bio Sciences Limited | 2.6 Million INR | -3494.905% |
| Kwality Pharmaceuticals Limited | 248.93 Million INR | 62.331% |
| Makers Laboratories Limited | 83.1 Million INR | -12.836% |
| Panchsheel Organics Limited | 68.15 Million INR | -37.577% |
| Parnax Lab Limited | 80.59 Million INR | -16.353% |
| PRAVEG LIMITED | 77.18 Million INR | -21.493% |
| Mercury Laboratories Limited | 217.24 Million INR | 56.836% |
| Trident Lifeline Limited | 46.87 Million INR | -100.062% |
| Vikram Thermo (India) Limited | 104.27 Million INR | 10.074% |
| Vivanza Biosciences Limited | 4.55 Million INR | -1958.639% |
| Zenlabs Ethica Limited | 57.89 Million INR | -61.967% |
| SHELTER PHARMA LIMITED | 12.3 Million INR | -662.335% |
| Vasundhara Rasayans Limited | 145.5 Million INR | 35.556% |
| Bharat Immunologicals & Biologicals Corporation Limited | 184.08 Million INR | 49.06% |
| Roopa Industries Limited | 24.63 Million INR | -280.641% |
| PANJON LTD. | 33.77 Million INR | -177.601% |
| Pharmaids Pharmaceuticals Limited | 76.49 Million INR | -22.586% |
| TIAAN CONSUMER LIMITED | 107 Thousand INR | -87536.449% |
| Anuh Pharma Limited | 263.04 Million INR | 64.352% |
| Crestchem Limited | 50.8 Million INR | -84.579% |
| Emmessar Biotech & Nutrition Limited | 4.32 Million INR | -2069.621% |
| Sandu Pharmaceuticals Limited | 212.9 Million INR | 55.956% |
| Fredun Pharmaceuticals Limited | 360.45 Million INR | 73.986% |
| Trimurthi Limited | 4.81 Million INR | -1849.096% |
| Shukra Pharmaceuticals Limited | 83.05 Million INR | -12.905% |
| Norris Medicines Limited | 18.2 Million INR | -415.08% |
| Veerhealth Care Limited | 15.38 Million INR | -509.615% |
| Lactose (India) Limited | 111.66 Million INR | 16.022% |
| OXYGENTA PHARMACEUTICAL LIMITE | 23.78 Million INR | -294.327% |
| Ambalal Sarabhai Enterprises Limited | 280.83 Million INR | 66.609% |
| Gennex Laboratories Limited | 130.37 Million INR | 28.077% |
| Godavari Drugs Limited | 359.01 Million INR | 73.881% |
| Zenotech Laboratories Limited | 94.82 Million INR | 1.108% |
| Shree Ganesh Remedies Limited | 104.13 Million INR | 9.952% |
| Bharat Parenterals Limited | 255.97 Million INR | 63.368% |
| Coral Laboratories Limited | 189.75 Million INR | 50.584% |
| Evoq Remedies Limited | 4.51 Million INR | -1975.957% |
| Kerala Ayurveda Limited | 399.64 Million INR | 76.536% |
| KOBO BIOTECH LIMITED | 2.48 Million INR | -3681.089% |
| Natural Capsules Limited | 444.7 Million INR | 78.914% |
| Auro Laboratories Limited | 157.37 Million INR | 40.416% |